Innoviva
$15.079876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$15.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-0.23%) As of 2:15 PM EST today
-$0.04 (-0.23%) Today
Why Robinhood?
You can buy or sell Innoviva and other stocks, options, ETFs, and crypto commission-free!
About INVA
Innoviva, Inc. Common Stock, also called Innoviva, is engaged in the development, commercialization, and financial management of bio-pharmaceuticals. Read More Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.
Employees
6
Headquarters
Brisbane, California
Founded
1996
Market Cap
1.53B
Price-Earnings Ratio
10.55
Dividend Yield
—
Average Volume
892.54K
High Today
$15.30
Low Today
$15.05
Open Price
$15.10
Volume
242.38K
52 Week High
$16.29
52 Week Low
$10.03
Collections
INVA Earnings
$0.00
$0.22
$0.43
$0.65
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 29, After Hours
People Also Bought
Gilead Sciences
15,571
$69.23
+3.33%ViacomCBS
3,455
$28.48
-2.78%GrafTech
1,225
$9.89
-0.10%Allison Transmission
363
$44.61
+1.18%MSG Networks
303
$13.98
-2.31%HP
9,405
$22.59
-0.22%Biogen
1,923
$336.02
-0.18%Altria
18,461
$45.98
+0.92%MasterCraft Boat
483
$19.22
-1.08%Applied Materials
16,637
$63.92
-3.73%Arena Pharmaceuticals
2,149
$52.66
-1.07%Bristol-Myers Squibb
7,854